Cromolyn sodium is an anti-inflammatory medication best known for preventing allergic reactions and asthma attacks rather than treating them once they start. Unlike antihistamines, which block the effects of histamine after it has been released, cromolyn works upstream by stabilizing the cells that release histamine and other inflammatory chemicals in the first place. That preventive character makes it unusual among allergy and asthma drugs, and it has led to a surprisingly wide range of uses, from eye drops and nasal sprays to an oral form used for a rare condition involving runaway mast cells.
How Cromolyn Sodium Works
The core action of cromolyn is mast cell stabilization. Mast cells are immune cells found throughout your body’s tissues, especially in the skin, lungs, gut lining, and around blood vessels. When an allergen binds to antibodies on a mast cell’s surface, the cell degranulates, dumping histamine and a cocktail of other inflammatory chemicals into surrounding tissue. That cascade produces the swelling, itching, mucus production, and airway constriction familiar to anyone with allergies or asthma. Cromolyn prevents this by keeping the mast cell membrane from opening up, so the inflammatory cargo stays locked inside.
But mast cell stabilization is not the whole story. Cromolyn also blocks mediator release triggered by non-allergic stimuli like exercise and cold air, and it is the only asthma medication shown to block both the early and late phases of the airway response to allergen inhalation.1PubMed Central. Cromolyn sodium: a review of mechanisms and clinical use in asthma Research has also found that cromolyn can directly inhibit eosinophil infiltration, a type of white blood cell heavily involved in allergic inflammation, through pathways that do not depend on mast cells at all.2PubMed. Disodium cromoglycate inhibits capsaicin-induced eosinophil infiltration of conjunctiva independent of mast cells In other words, the drug influences multiple branches of the inflammatory response, which partly explains why it is useful across so many different tissues and conditions.
A Drug Born from Self-Experimentation
Cromolyn sodium owes its existence to a physician who was also his own test subject. Roger Altounyan, an Anglo-Armenian doctor working in England, suffered from severe allergies himself. In the 1960s he began studying khellin, a compound from the plant Ammi visnaga that had been used in traditional Middle Eastern medicine. Through systematic self-testing, deliberately exposing himself to allergens and then measuring his airway response, Altounyan identified a khellin derivative that could protect against allergic bronchoconstriction.3PubMed. From khellin to sodium cromoglycate–a tribute to the work of Dr. R. E. C. Altounyan (1922-1987) That derivative became cromolyn sodium, introduced commercially in the late 1960s as one of the first preventive asthma therapies. The discovery was unusual for the pharmaceutical world: rather than emerging from high-throughput screening or animal models, it came from a doctor inhaling allergens and then testing candidate drugs on his own lungs.
The Asthma Role, Then and Now
For decades, inhaled cromolyn was a go-to controller medication for mild persistent asthma, particularly in children. Parents liked it because its safety record was, and remains, essentially unmatched among asthma drugs. The side-effect profile is remarkably clean: throat irritation and cough from the dry-powder inhaler were the main complaints, and serious adverse events were rare even with long-term use.4PubMed. Cromolyn sodium: fitting an old friend into current asthma treatment
That said, cromolyn has largely been displaced in asthma management. A major Cochrane review comparing inhaled corticosteroids to cromolyn in both children and adults concluded that corticosteroids are more effective for controlling persistent asthma, supporting guideline recommendations that now favor corticosteroids as first-line maintenance therapy.5PubMed Central. Inhaled corticosteroids versus sodium cromoglycate in children and adults with asthma Cromolyn is not a rescue drug either; it does nothing to reverse an asthma attack already in progress. Its usefulness lies in prevention, and in that arena, corticosteroids have proven more potent.
Where cromolyn still has a foothold is in exercise-induced bronchospasm. Taken a few minutes before physical activity, it protects against exercise-triggered airway narrowing in more than 70% of patients.6PubMed. The use of cromolyn in the management of hyperreactive airways and exercise That protection is not quite as strong as what you get from inhaled albuterol, which remains the preferred pre-exercise option for most people. A head-to-head trial in exercise-induced bronchospasm showed albuterol providing better prophylaxis than either acute or chronic cromolyn use.7PubMed. A comparison of inhaled albuterol and cromolyn in the prophylaxis of exercise-induced bronchospasm Still, for someone who cannot tolerate beta-agonists or prefers to avoid them, cromolyn offers a genuine alternative with virtually no systemic side effects.
Allergic Eye and Nasal Symptoms
Cromolyn sodium is available over the counter in both eye-drop and nasal-spray forms, and these remain among its most common uses. For seasonal allergic conjunctivitis, the eye drops significantly reduce itching, tearing, and redness compared to placebo.8Journal of Allergy and Clinical Immunology. Cromolyn sodium in seasonal allergic conjunctivitis Timing matters, though. Research has found that starting cromolyn eye drops before allergy season begins and using them on a regular schedule is more effective at preventing symptom flare-ups than waiting until symptoms appear and using the drops on an as-needed basis.9Journal of Allergy and Clinical Immunology. Sodium cromoglycate eye drops: Regular versus “as needed” use in the treatment of seasonal allergic conjunctivitis This is consistent with cromolyn’s preventive nature: it stops the mast cell cascade from starting, but once the cascade is already underway, the drug has limited power to shut it down.
The nasal spray tells a similar story. A large placebo-controlled trial involving over 1,100 patients found that cromolyn nasal spray provided significant relief of allergy symptoms including sneezing and nasal congestion.10PubMed. Efficacy and patient satisfaction with cromolyn sodium nasal solution in the treatment of seasonal allergic rhinitis: a placebo-controlled study The effect, while real, is generally considered milder than what you get from nasal corticosteroid sprays or newer antihistamine sprays. Cromolyn’s advantage here is the same as everywhere else: the safety profile is exceptionally benign, making it attractive for pregnant women, young children, and anyone wary of steroid side effects.
The practical downside of both the eye drops and the nasal spray is the dosing schedule. Most formulations call for use four to six times a day, which demands a level of discipline that many people struggle with. Newer antihistamine drops often work with once- or twice-daily dosing, and that convenience gap is a big reason cromolyn has lost market share despite being safe and effective.
Systemic Mastocytosis and Mast Cell Disorders
Oral cromolyn sodium occupies an interesting niche in the treatment of systemic mastocytosis, a rare condition in which abnormal mast cells accumulate in organs like the skin, bone marrow, liver, and gastrointestinal tract. These excess mast cells release bursts of histamine and other mediators, causing episodes of flushing, itching, abdominal pain, diarrhea, and sometimes cognitive difficulties.
A landmark double-blind crossover study in patients with systemic mastocytosis found that oral cromolyn produced marked improvement in symptoms including pruritus, flushing, diarrhea, abdominal pain, and even cognitive disturbances.11PubMed. Oral disodium cromoglycate in the treatment of systemic mastocytosis A later multicenter double-blind trial confirmed the benefit, finding that patients withdrawn from cromolyn and switched to placebo experienced significant worsening of symptoms, especially gastrointestinal ones like diarrhea, abdominal pain, nausea, and vomiting.12PubMed. Cromolyn sodium in the management of systemic mastocytosis
Current reviews consider cromolyn a treatment of choice for the gastrointestinal manifestations of mastocytosis, alongside antihistamines.13PubMed. Gastrointestinal Manifestations of Hypereosinophilic Syndromes and Mast Cell Disorders: a Comprehensive Review The oral form works here partly because of a quirk of pharmacokinetics: the drug is very poorly absorbed from the gut. In rat studies, its absolute oral bioavailability was estimated at only about 5%.14PubMed. Oral delivery of sodium cromolyn: preliminary studies in vivo and in vitro In a sense, the poor absorption is a feature rather than a bug for gut-related mast cell problems: the drug stays concentrated right where it is needed, lining the gastrointestinal mucosa, and stabilizes mast cells locally without flooding the bloodstream. That same poor absorption is why oral cromolyn never gained traction as a systemic asthma treatment and why the inhaled route was always necessary for lung conditions.
Mast Cell Activation Syndrome and Higher Doses
In recent years, oral cromolyn has attracted attention for mast cell activation syndrome (MCAS), a condition distinct from mastocytosis. In MCAS, mast cells are not necessarily overabundant, but they misbehave, releasing mediators excessively in response to various triggers. Symptoms can overlap with those of mastocytosis and range widely, from skin flushing and hives to gut symptoms, brain fog, and fatigue.
A case series of five patients with MCAS, some of whom also met criteria for myalgic encephalomyelitis/chronic fatigue syndrome, reported that a continuous oral regimen of high-dose cromolyn, between 1,600 and 2,400 milligrams daily, was effective in controlling signs and symptoms of mast cell activation. That dose range is substantially higher than the standard 800 milligrams per day typically prescribed for mastocytosis, but it fell within the safety limits specified in the drug’s original FDA application.15PubMed Central. A Continuous Oral Regimen of High-Dose Cromolyn Sodium Is Effective for Some Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Patients With Mast Cell Activation Syndrome This is preliminary evidence from a very small number of patients, not a controlled trial, and the findings should be understood accordingly. But for people with MCAS who have exhausted other options, oral cromolyn is increasingly being tried by specialists.
Topical Use in Atopic Dermatitis
An application that never quite reached the mainstream is topical cromolyn for eczema. Given that mast cells play a role in the skin inflammation of atopic dermatitis, the rationale for applying a mast cell stabilizer directly to eczematous skin is straightforward. A double-blind trial in young children found that topically applied cromolyn solution significantly improved dermatitis, itching, and sleep disturbance with no adverse effects.16PubMed. Topical cromolyn (disodium cromoglycate) solution in the treatment of young children with atopic dermatitis A separate study of topical cromolyn in a hydrophilic emollient vehicle demonstrated a significant anti-inflammatory effect in moderate-to-severe atopic dermatitis, with the investigators incorporating the treatment into their clinical practice.17PubMed. Topical sodium cromoglycate in the treatment of moderate-to-severe atopic dermatitis
Despite these positive results, topical cromolyn for eczema never became a standard treatment. The dermatology field moved toward topical calcineurin inhibitors and, more recently, biologic drugs, which offered stronger efficacy for moderate-to-severe disease. Cromolyn’s topical formulations for the skin remain largely a curiosity, used occasionally by allergists and dermatologists willing to compound it, rather than a commercially available product.
Chronic Cough in Pulmonary Fibrosis
One of the more unexpected recent developments involves a reformulated inhaled version of cromolyn sodium being tested for chronic cough in idiopathic pulmonary fibrosis (IPF). IPF is a progressive scarring disease of the lungs, and chronic cough is one of its most debilitating symptoms, with few effective treatments available. A phase 2 trial found that an inhaled cromolyn formulation reduced daytime cough frequency by about 31% over two weeks compared with placebo in IPF patients.18PubMed. A novel formulation of inhaled sodium cromoglicate (PA101) in idiopathic pulmonary fibrosis and chronic cough: a randomised, double-blind, proof-of-concept, phase 2 trial
A subsequent multicenter phase 2B trial, called the SCENIC trial, built on those initial findings. The earlier phase 2A study had demonstrated reductions in both daytime and 24-hour average cough counts in IPF patients.19American Journal of Respiratory and Critical Care Medicine. Phase 2B Study of Inhaled RVT-1601 for Chronic Cough in Idiopathic Pulmonary Fibrosis: A Multicenter, Randomized, Placebo-controlled Study (SCENIC Trial) The cough-reduction effect likely reflects something beyond classical mast cell stabilization, possibly involving nerve-related pathways in the fibrotic lung. If confirmed in larger trials, this would be a meaningful new indication for a drug that has been around for over fifty years.
Experimental Alzheimer’s Research
Perhaps the most surprising line of cromolyn research has nothing to do with allergy at all. A preclinical study in mice engineered to develop Alzheimer’s-like pathology found that cromolyn, alone or combined with ibuprofen, reduced levels of the amyloid-beta protein that forms the hallmark plaques of Alzheimer’s disease. The drug appeared to work by shifting the brain’s immune cells into a cleanup state, promoting their ability to engulf and clear amyloid deposits rather than simply producing more inflammation.20PubMed Central. Cromolyn Reduces Levels of the Alzheimer’s Disease-Associated Amyloid β-Protein by Promoting Microglial Phagocytosis
This is mouse data, and the distance between clearing amyloid in a genetically engineered mouse brain and treating human Alzheimer’s disease is enormous. Many compounds that looked promising in this exact kind of experiment have failed in human trials. Still, the finding generated enough interest to motivate further study, in part because cromolyn’s long safety record makes it relatively easy to move into human testing. A nasal formulation designed to improve brain delivery has entered clinical development, though results from human trials have not yet demonstrated efficacy.
Why Cromolyn Keeps Getting Overlooked
For a drug with such a broad range of activity and an almost spotless safety record, cromolyn sodium has a strange tendency to get sidelined. Part of this is purely practical: the need to dose it multiple times a day makes it less convenient than once-daily alternatives. Part of it is the modest effect size. Cromolyn works, but in most head-to-head comparisons it is not the strongest option in its category. In asthma, inhaled corticosteroids outperform it. For nasal allergies, steroid sprays and modern antihistamines do more. For eye allergies, newer mast cell stabilizer/antihistamine combination drops have absorbed most of its market.
There is also an economic dimension. Cromolyn is long off patent, and the profit margins on generic, off-patent drugs are slim. That means limited incentive for pharmaceutical companies to fund the large clinical trials that could establish cromolyn in newer indications like MCAS or IPF-associated cough. The drug ends up in a kind of therapeutic limbo: too safe and too cheap to attract investment, not quite powerful enough to dominate any single indication, but genuinely useful across a surprising number of them.
For patients and clinicians who prioritize tolerability, especially for young children, pregnant women, or people with multiple chemical sensitivities, cromolyn remains a tool worth knowing about. Its mechanism is distinct from corticosteroids, antihistamines, and leukotriene modifiers, which means it can sometimes fill a gap when other drugs cause intolerable side effects or fall short on their own. The trick is remembering that it needs to be taken consistently and preventively. Reaching for it in the middle of a flare and expecting immediate relief is a recipe for disappointment and, unfortunately, a common reason people conclude the drug does not work.